Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

Rep. Katie Porter (D-Calif.) took Big Pharma CEOs to task for charging exorbitant prices for life-saving medications during a House Oversight Committee hearing on September 30, 2020. (Photo: Tom Williams/CQ-Roll Call, Inc. via Getty Images)

Rep. Katie Porter (D-Calif.) speaks during a House Financial Services Committee hearing on Tuesday, October 22, 2019. (Photo: Tom Williams/CQ-Roll Call, Inc. via Getty Images)

WATCH: Katie Porter, Squad Members Eviscerate Big Pharma CEOs Over 'Exorbitant' Drug Prices

"To recap here: The drug didn't get any better, the cancer patients didn't get any better, you just got better at making money—you just refined your skills at price gouging." 

Brett Wilkins

House Democrats—including three Squad members—tore into pharmaceutical industry chief executives during a Wednesday congressional hearing on Big Pharma profiteering, with Rep. Katie Porter verbally eviscerating one CEO for more than tripling the price of a critical cancer drug. 

Wednesday marked the first day of a two-day House Oversight Committee hearing titled "Unsustainable Drug Prices: Testimony from the CEOs." Bristol Myers Squibb CEO Giovanni Caforio, Teva Pharmaceuticals CEO Kåre Schultz, and former Celgene CEO Mark Alles all endured nearly four hours of grilling over the price of prescription drugs—which are almost always far more expensive in the United States than anywhere else in the world.

Porter (D-Calif.), a former consumer protection attorney, was the most ferocious committee member to address the CEOs. Bringing out her infamous white board, she attacked Celgene's repeated price hikes for the cancer drug Revlimid, which now costs $763 per dose—in 2005 it cost $215. When Alles attempted to explain that the drug has been approved for new uses, Porter hit back, and hard.

"Did the drug start to work faster? Were there fewer side effects? How did you change the formula or production of Revlimid to justify this price increase?" Porter asked. "To recap here: The drug didn't get any better, the cancer patients didn't get any better, you just got better at making money—you just refined your skills at price gouging."

Porter has built a reputation for speaking tough truth to power, on issues ranging from defending access to crucial public benefits, to challenging mega-bank CEOs on income inequality, to exposing the pernicious influence of dark money in politics.

Toward the end of Wednesday's nearly four-hour session, three of the four members of the so-called Squad—Reps. Rashida Tlaib (D-Mich.), Ayanna Pressley (D-Mass.), and Alexandria Ocasio-Cortez (D-N.Y.)—slammed the CEOs over what Ocasio-Cortez called the "exorbitant cost" of life-saving medications. 

Armed with a chart showing the cost of 40 milligrams of Teva's multiple sclerosis drug Copaxone is more than five times as high in the U.S. as in Britain, Ocasio-Cortez refuted an assertion by Schultz that medications cost more in the United States because American patients have "very broad, and very early access" to new drugs.

Citing Teva's own internal documents, Ocasio-Cortez showed the company was forced to lower prices by European governments—which unlike the U.S. have instituted spending controls—even as it raised prices for American patients.

Pressley asserted that "the lack of access to affordable life-saving medicine is an injustice [that] represents an act of economic violence and an attack on the basic principle that healthcare is a fundamental human right," while Tlaib ripped Schultz for using charitable donations like "a side hustle."

"Your pharmaceutical company makes these so-called charitable donations so you look like you give a shit about sick people," said Tlaib. "But in reality these are just another scheme by your corporation to make money off of sick people."


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

This is the world we live in. This is the world we cover.

Because of people like you, another world is possible. There are many battles to be won, but we will battle them together—all of us. Common Dreams is not your normal news site. We don't survive on clicks. We don't want advertising dollars. We want the world to be a better place. But we can't do it alone. It doesn't work that way. We need you. If you can help today—because every gift of every size matters—please do. Without Your Support We Simply Don't Exist.

Biden-Backed Aukus Deal Could Spell 'Disaster' for Climate Cooperation With China

One U.K. lawmaker said reaching a "positive outcome" at the upcoming talks in Glasgow "just got a whole lot harder."

Jon Queally ·


Exclusive: Jared Kushner's Family Firm Set to Unleash Eviction Wave Amid Pandemic

"Kushner is the poster child for ultra-rich landlords clamoring to boost their bottom line by kicking families to the curb, even if it comes at the expense of public health."

Jake Johnson ·


Patient Group Targets Pair of Democrats for 'Selling Us Out to Drug Companies'

"It makes me so angry that members of Congress are choosing Big Pharma over patients. It's unforgivable."

Jake Johnson ·


Judge Blocks Biden From Continuing 'Inhumane' Trump Policy to Deport Families

"This is not the end of the battle against this practice," said one rights group, "but it is a major step to ensure that the U.S. welcomes these asylum-seeking families—as we should."

Jessica Corbett ·


400+ Economists Press Congress to Permanently Expand Child Tax Credit

Such an expansion would "dramatically reduce childhood poverty in the United States," they said.

Andrea Germanos ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.


Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo